Structure Therapeutics Inc (GPCR)
41.75
+0.22
(+0.53%)
USD |
NASDAQ |
Sep 27, 16:00
41.65
-0.10
(-0.24%)
After-Hours: 20:00
Structure Therapeutics Free Cash Flow: -105.32M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -105.32M |
| March 31, 2024 | -95.59M |
| December 31, 2023 | -81.66M |
| September 30, 2023 | -70.87M |
| Date | Value |
|---|---|
| June 30, 2023 | -60.04M |
| March 31, 2023 | -53.00M |
| December 31, 2022 | -46.28M |
Free Cash Flow Range, Past 5 Years
-105.32M
Minimum
Jun 2024
-46.28M
Maximum
Dec 2022
-73.25M
Average
-70.87M
Median
Sep 2023
Free Cash Flow Benchmarks
| Viking Therapeutics Inc | -71.94M |
| Eli Lilly and Co | -3.628B |
| Novo Nordisk AS | 9.505B |
| Amgen Inc | 5.481B |
| Pfizer Inc | 4.81B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -26.39M |
| Cash from Investing (Quarterly) | -204.52M |
| Cash from Financing (Quarterly) | 514.70M |
| Free Cash Flow Per Share (Quarterly) | -0.5428 |
| Free Cash Flow Yield | -5.59% |